Logo image of BRZE

BRAZE INC-A (BRZE) Stock Analyst Ratings

NASDAQ:BRZE - Nasdaq - US10576N1028 - Common Stock - Currency: USD

32.62  +1.19 (+3.79%)

After market: 33 +0.38 (+1.16%)

Buy % Consensus

84

ChartMill assigns a Buy % Consensus number of 84% to BRZE. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 53.79. This target is 64.9% above the current price.
BRZE was analyzed by 26 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about BRZE.
In the previous month the buy percentage consensus was at a similar level.
BRZE was analyzed by 26 analysts, which is quite many. So the average rating should be quite meaningful.
BRZE Historical Analyst RatingsBRZE Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -40 -36 -32 -28 -24 -20 -16 -12 -8 -4 0 5 10 15 20 25

Price Target & Forecast

Price Low Median Mean High 32.6238.3851.0053.7978.75 - 17.66% 56.35% 64.90% 141.42%
BRZE Current Analyst RatingBRZE Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 5 10 15
Up and Down Grades
Date Firm Action Rating
2025-04-23 Piper Sandler Maintains Overweight -> Overweight
2025-04-22 Wells Fargo Maintains Overweight -> Overweight
2025-04-14 DA Davidson Maintains Buy -> Buy
2025-03-28 Citizens Capital Markets Reiterate Market Outperform -> Market Outperform
2025-03-28 Needham Reiterate Buy -> Buy
2025-03-28 Stifel Maintains Buy -> Buy
2025-03-28 Wells Fargo Maintains Overweight -> Overweight
2025-03-28 Raymond James Maintains Outperform -> Outperform
2025-03-28 Canaccord Genuity Maintains Buy -> Buy
2025-03-28 Citigroup Maintains Buy -> Buy
2025-03-26 DA Davidson Maintains Buy -> Buy
2025-03-21 Wells Fargo Maintains Overweight -> Overweight
2025-03-20 Raymond James Maintains Outperform -> Outperform
2025-03-19 Stephens & Co. Initiate Overweight
2025-02-03 Needham Reiterate Buy -> Buy
2025-01-15 Needham Reiterate Buy -> Buy
2024-12-11 Macquarie Maintains Neutral -> Neutral
2024-12-11 Citigroup Maintains Buy -> Buy
2024-12-10 DA Davidson Maintains Buy -> Buy
2024-12-10 Needham Reiterate Buy -> Buy
2024-12-10 Oppenheimer Maintains Outperform -> Outperform
2024-12-10 Stifel Maintains Buy -> Buy
2024-12-10 Piper Sandler Maintains Overweight -> Overweight
2024-11-26 Wells Fargo Maintains Overweight -> Overweight
2024-11-12 Goldman Sachs Maintains Buy -> Buy
2024-10-31 Macquarie Initiate Neutral
2024-10-25 JP Morgan Maintains Overweight -> Overweight
2024-10-22 Stifel Initiate Buy
2024-10-10 Piper Sandler Maintains Overweight -> Overweight
2024-09-25 UBS Maintains Buy -> Buy